A Case of Unresectable Non-small-cell Lung Cancer That Rapidly Relapsed Refractory to Nivolumab After Long-term Disease Control

Authors

Takuya Tanimura
Takashi Iwata (ORCID: https://orcid.org/0000-0001-7846-9261)
Michihito Toda (ORCID: https://orcid.org/0000-0002-1909-9472)
Aya Yamamoto
Kantaro Hara (ORCID: https://orcid.org/0000-0002-2319-9791)
Ryuichi Ito
Hisaya Chikaraishi

Institutions

Kansai Rosai Hospital (JP)

Publication Details

Journal: Haigan
Published: 2024-10-20
DOI: https://doi.org/10.2482/haigan.64.860
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Case of Unresectable Non-small-cell Lung Cancer That Rapidly Relapsed Refractory to Nivolumab After Long-term Disease Control

Takuya Tanimura, Takashi Iwata, Michihito Toda, Aya Yamamoto et al.

Oct 20, 2024

Haigan

Cancer Immunotherapy and Biomarkers

article

A Case of Unresectable Non-small-cell Lung Cancer That Rapidly Relapsed Refractory to Nivolumab After Long-term Disease Control

Takuya Tanimura, Takashi Iwata, Michihito Toda, Aya Yamamoto, Kantaro Hara, Ryuichi Ito, Hisaya Chikaraishi

October 20, 2024article en

Abstract

No abstract available for this paper.

HaiganVol. 64(6)

Kansai Rosai Hospital (JP)

Good health and well-being

Openalex Percentile: Top 66%

Cancer Immunotherapy and Biomarkers

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Case of Unresectable Non-small-cell Lung Cancer That Rapidly Relapsed Refractory to Nivolumab After Long-term Disease Control — Takuya Tanimura, Takashi Iwata, et al. · Haigan (2024) | TGRS Research Map | TGRS